Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,0412,060 of 20,252 grants

Active NON-SBIR/STTR RPGS
Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

Project Summary/Abstract Acute myeloid leukemia (AML) continues to have a dismal 5-year survival rate of

$5.54M
USD
Active NON-SBIR/STTR RPGS
A framework for integrating MR imaging and clinical tests for prediction of outcomes in multiple myeloma treatment
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

Abstract Multiple myeloma (MM) is the second most common hematologic malignancy (after non-Hodgkin lymphoma) in the U.S. Over the past decade, despite the advent of novel therapies...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Induction of interferon response by chromatin damaging anti-cancer therapy
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2028

Abstract. DNA-targeting drugs are a mainstream therapy for cancer, but it is becoming clearer that some of their anti-cancer activity is due not only to DNA damage, but also chroma...

$3.97M
USD
Active NON-SBIR/STTR RPGS
Interrogating Type I Interferon signaling in breast cancer brain metastasis
NATIONAL CANCER INSTITUTE Wistar Institute United States 2023 – 2028

PROJECT SUMMARY The brain is one of the common organs for breast cancer recurrence. Breast cancer brain metastasis is increasingly becoming a significant clinical problem due to it...

$5.29M
USD
Completed OTHER RESEARCH-RELATED
33rd International Workshop on Retroviral Pathogenesis
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2024

Project Summary/Abstract The International Workshop on Retroviral Pathogenesis, now in its 33rd year, has long served as a forum for the exchange of new research findings and conce...

$100K
USD
Completed NON-SBIR/STTR RPGS
Exploring SGLTs as Theranostic Targets for Cancer Metastasis
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2025

Project Summary/Abstract: Exploring SGLTs as Theranostic Targets for Cancer Metastasis Cancer requires substantial energy that is commonly provided by increased glucose transport a...

$2.36M
USD
Completed NON-SBIR/STTR RPGS
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2025

Project Summary One of the most harmful side effects of chemotherapy is chemotherapy-induced peripheral neuropathy (CIPN), a common, painful, and disabling side effect of many chem...

$6.03M
USD
Completed OTHER RESEARCH-RELATED
Precision Approaches to Treat Mantle Cell Lymphoma: Integrating Multi-omics Based Models
NATIONAL CANCER INSTITUTE Rice University United States 2023 – 2024

Project Summary Mantle cell lymphoma (MCL) is a rare, incurable form of non Hodgkin lymphoma which is disposed to therapeutic resistance and relapse. Though rare, MCL is both clini...

$872.5K
USD
Completed SBIR-STTR RPGS
Targeting OSCC cells with a lozenge to treat oral cancer
NATIONAL CANCER INSTITUTE Sentrimed, Inc United States 2023 – 2025

Abstract/Summary Oral cancer kills over 8,000 people in the USA and 120,000 people worldwide every year. Over 90% of oral cancers are caused by oral squamous cell carcinoma (OSCC),...

$2.48M
USD
Completed TRAINING, INDIVIDUAL
The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2023 – 2024

Abstract Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate of all major cancers. While immunotherapy has revolutionized treatment for numerous cancers, such tr...

$25K
USD
Completed NON-SBIR/STTR RPGS
BET degraders for improving colorectal cancer therapy
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the US. Developing novel and more effective CRC therapies is an unmet biome...

$4.18M
USD
Completed NON-SBIR/STTR RPGS
BET degraders for improving colorectal cancer therapy
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the US. Developing novel and more effective CRC therapies is an unmet biome...

$4.23M
USD
Active NON-SBIR/STTR RPGS
A precision medicine basis for estrogen therapy for advanced breast cancer
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2023 – 2027

Project Summary: It remains unknown why some estrogen receptor alpha (ER)-positive breast cancers are sensitive to estrogen therapy while others are resistant, and strategies for e...

$3.6M
USD
Active NON-SBIR/STTR RPGS
A precision medicine basis for estrogen therapy for advanced breast cancer
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2023 – 2027

Project Summary: It remains unknown why some estrogen receptor alpha (ER)-positive breast cancers are sensitive to estrogen therapy while others are resistant, and strategies for e...

$1.43M
USD
Completed TRAINING, INDIVIDUAL
Role of PDK1 in pancreatic cancer cell fitness under tumor nutrient stress
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2025

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type in urgent need of more effective treatment options. A notable feature of PDAC tumors is t...

$476.9K
USD
Completed NON SBIR/STTR CONTRACTS
PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS
NATIONAL CANCER INSTITUTE Ccs Associates, Inc United States 2023 – 2024

THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUAL...

$24.03M
USD
Completed NON SBIR/STTR CONTRACTS
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING
NATIONAL CANCER INSTITUTE Ccs Associates, Inc United States 2023 – 2024

THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI).

$29.75M
USD
Active TRAINING, INDIVIDUAL
Conserved coamplification event in HER2+ breast cancer increases metastasis
NATIONAL CANCER INSTITUTE Michigan State University United States 2023 – 2026

PROJECT SUMMARY Breast cancer is the most common cancer diagnosed among women and is estimated to be the leading cause of death for women worldwide. Approximately one fifth of brea...

$476.9K
USD
Completed NON SBIR/STTR CONTRACTS
FY23 FACILITIES TO C-WESTLAKE REFURBISHMENT
NATIONAL CANCER INSTITUTE Leidos Biomedical Research, Inc United States 2023 – 2025

Building 560 is a 183,548 sq. ft. masonry and steel structure constructed in 1956. This project will refurbish Wing 2, Floor 2 of Building 560, specifically Room Nos. 22-31, 22-56...

$30.71M
USD
Active OTHER RESEARCH-RELATED
Targeting a Novel Pocket on ITGAV
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2023 – 2027

Project Summary. Cancer deaths remain at an all-time high in the United States leaving an urgent clinical need to develop novel therapeutic strategies to help patients. The lack of...

$909.5K
USD